Alyeska Investment Group, L.P. - 30 Sep 2025 SCHEDULE 13G Report for INOVIO PHARMACEUTICALS Class A Common Stock, $0.001 par value (INO)

Filing Manager
Alyeska Investment Group, L.P.
Reporting Manager
Alyeska Investment Group, L.P.
Security
INOVIO PHARMACEUTICALS Class A Common Stock, $0.001 par value
Symbol
INO
Shares outstanding
53,120,850 shares
Disclosed Ownership
4,000,000 shares
Ownership
7.5%
Form type
SCHEDULE 13G
Filing time
14 Nov 2025, 20:01:29 UTC
Date of event
30 Sep 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Alyeska Investment Group, L.P. 7.5% 4,000,000 0 4,000,000 Jason Bragg Jason Bragg | Chief Financial Officer
Alyeska Fund GP, LLC 7.5% 4,000,000 0 4,000,000 Jason Bragg Jason Bragg | Chief Financial Officer
Anand Parekh 7.5% 4,000,000 0 4,000,000 Anand Parekh Anand Parekh | Self